Search Results - "Sweiss, Nadera J."

Racial Difference in Sarcoidosis Mortality in the United States by Mirsaeidi, Mehdi, MD, MPH, Machado, Roberto F., MD, Schraufnagel, Dean, MD, FCCP, Sweiss, Nadera J., MD, Baughman, Robert P., MD, FCCP

“…BACKGROUND The clinical presentation and outcome of sarcoidosis varies by race. However, the race difference in mortality outcome remains largely unknown…”
Get full text

Established and experimental medical therapy of pulmonary sarcoidosis by BAUGHMAN, Robert P, NUNES, Hilario, SWEISS, Nadera J, LOWER, Elyse E

“…The treatment options for pulmonary sarcoidosis have increased over the past 10 years. As new treatments have been introduced, the best way to assess and…”
Get full text

Efzofitimod for the Treatment of Pulmonary Sarcoidosis by Culver, Daniel A., Aryal, Shambhu, Barney, Joseph, Hsia, Connie C.W., James, W. Ennis, Maier, Lisa A., Marts, Lucian T., Obi, Ogugua Ndili, Sporn, Peter H.S., Sweiss, Nadera J., Shukla, Sanjay, Kinnersley, Nelson, Walker, Gennyne, Baughman, Robert

“…Pulmonary sarcoidosis is characterized by the accumulation of immune cells that form granulomas affecting the lungs. Efzofitimod (ATYR1923), a novel…”
Get full text

Cardiac Sarcoidosis Detected by Late Gadolinium Enhancement and Prevalence of Atrial Arrhythmias by Cain, Matthew A., MD, Metzl, Mark D., MD, Patel, Amit R., MD, Addetia, Karima, MD, Spencer, Kirk T., MD, Sweiss, Nadera J., MD, Beshai, John F., MD

“…Cardiovascular magnetic resonance (CMR) imaging is being increasingly used to help identify patients with cardiac sarcoidosis (CS). Whereas ventricular…”
Get full text

Detection of early phenotype cardiac sarcoidosis by cardiovascular magnetic resonance by Levin, Benjamin, Baughman, Robert P., Sweiss, Nadera J.

“…Purpose of review Cardiac sarcoidosis has high prevalence in sarcoidosis patients and contributes to significant morbidity and mortality. Early detection of…”
Get full text

What Is the Optimal Method on Myocardial Suppression in FDG PET/CT Evaluation of Cardiac Sarcoidosis? by Lu, Yang, Sweiss, Nadera J., Macapinlac, Homer A.

“…Based on the recent publications, including large cohort retrospective study and prospective clinical trial data, we are commenting on the optimal methods on…”
Get full text

Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis by Ascoli, Christian, Schott, Cody A, Huang, Yue, Turturice, Benjamin A, Wang, Wangfei, Ecanow, Naomi, Sweiss, Nadera J, Perkins, David L, Finn, Patricia W

“…In sarcoidosis, peripheral lymphopenia and anergy have been associated with increased inflammation and maladaptive immune activity, likely promoting…”
Get full text

Editorial: Sarcoidosis—The great mimicker by Korsten, Peter, Mirsaeidi, Mehdi, Sweiss, Nadera J.

Get full text

Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis by Zhou, Tong, Zhang, Wei, Sweiss, Nadera J, Chen, Edward S, Moller, David R, Knox, Kenneth S, Ma, Shwu-Fan, Wade, Michael S, Noth, Imre, Machado, Roberto F, Garcia, Joe G N

“…Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in ~20% of cases progresses with severe lung…”
Get full text

Reproducibility and rigor in rheumatology research by Alnaimat, Fatima, Sweis, Nadia J, Sweis, Jaleel Jerry G, Ascoli, Christian, Korsten, Peter, Rubenstein, Israel, Sweiss, Nadera J

“…The pillars of scientific progress in rheumatology are experimentation and observation, followed by the publication of reliable and credible results. These…”
Get full text

Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis by Aronov, Avi, Kim, Yoo Jin, Sweiss, Nadera J, Nazir, Noreen T.

“…Although rheumatoid arthritis (RA) results in a 50% increased risk of cardiovascular disease mortality, comparable to the risk associated with diabetes…”
Get full text

Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations by Sweiss, Nadera J, Salloum, Rafah, Gandhi, Seema, Ghandi, Seema, Alegre, Maria-Luisa, Sawaqed, Ray, Badaracco, Maria, Pursell, Kenneth, Pitrak, David, Baughman, Robert P, Moller, David R, Garcia, Joe G N, Niewold, Timothy B

“…Sarcoidosis is a poorly understood chronic inflammatory condition. Infiltration of affected organs by lymphocytes is characteristic of sarcoidosis, however…”
Get full text

Corrigendum: Reproducibility and rigor in rheumatology research by Alnaimat, Fatima, Sweis, Nadia J., Sweis, Jaleel Jerry G., Ascoli, Christian, Korsten, Peter, Rubinstein, Israel, Sweiss, Nadera J.

Get full text

Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study by Rahaghi, Franck F, Sweiss, Nadera J, Saketkoo, Lesley Ann, Scholand, Mary Beth, Barney, Joseph B, Gerke, Alicia K, Lower, Elyse E, Mirsaeidi, Mehdi, O'Hare, Lanier, Rumbak, Mark J, Samavati, Lobelia, Baughman, Robert P

“…In patients treated with repository corticotrophin injection (RCI) for pulmonary sarcoidosis, effective management of adverse events may improve adherence…”
Get full text

Unsupervised Clustering Reveals Sarcoidosis Phenotypes Marked by a Reduction in Lymphocytes Relate to Increased Inflammatory Activity on 18FDG-PET/CT by Vagts, Christen, Ascoli, Christian, Fraidenburg, Dustin R, Baughman, Robert P, Huang, Yue, Edafetanure-Ibeh, Russell, Ahmed, Samreen, Levin, Benjamin, Lu, Yang, Perkins, David L, Finn, Patricia W, Sweiss, Nadera J

“…Sarcoidosis is a T-helper cell mediated disease characterized by granulomatous inflammation. We posited that unsupervised clustering of various features in…”
Get full text

Trimer IgG and neutralising antibody response to COVID-19 mRNA vaccination in individuals with sarcoidosis by Vagts, Christen L, Chang, Yi-Shin, Ascoli, Christian, Lee, Jessica M, Huang, Kai, Huang, Yue, Cherian, Ruth A, Sarup, Nandini, Warpecha, Samantha R, Edafetanure-Ibeh, Russell, Amin, Md-Ruhul, Sultana, Tasmin, Ghassemi, Mahmood, Sweiss, Nadera J, Novak, Richard, Perkins, David L, Finn, Patricia W

“…Individuals with sarcoidosis are at higher risk for infection owing to underlying disease pathogenesis and need for immunosuppressive treatment. Current…”
Get full text

Drug-Induced Granulomatous Interstitial Nephritis in a Patient With Ankylosing Spondylitis During Therapy With Adalimumab by Korsten, Peter, MD, Sweiss, Nadera J., MD, Nagorsnik, Ulf, MD, Niewold, Timothy B., MD, Gröne, Hermann-Josef, MD, Gross, Oliver, MD, Müller, Gerhard A., MD

“…Tumor necrosis factor α (TNF-α) inhibitors are used in the treatment of rheumatoid arthritis, psoriasis, psoriatic arthritis, Crohn disease, ankylosing…”
Get full text

Circulating cytokines in sarcoidosis: Phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease by Patterson, Karen C., Franek, Beverly S., Müller-Quernheim, Joachim, Sperling, Anne I., Sweiss, Nadera J., Niewold, Timothy B.

“…► Circulating IL-5 is significantly decreased in patients with chronic sarcoidosis. ► Circulating IL-7 is significantly increased in chronic sarcoidosis…”
Get full text

Gene Co-expression Networks Identifies Common Hub Genes Between Cutaneous Sarcoidosis and Discoid Lupus Erythematosus by Nickles, Melissa A, Huang, Kai, Chang, Yi-Shin, Tsoukas, Maria M, Sweiss, Nadera J, Perkins, David L, Finn, Patricia W

“…In this study we analyzed gene co-expression networks of three immune-related skin diseases: cutaneous sarcoidosis (CS), discoid lupus erythematosus (DLE), and…”
Get full text

Sarcoidosis: can tofacitinib slay the dragon? by Sweiss, Nadera J., Baughman, Robert

“…Lack of understanding of the immunology of sarcoidosis has limited therapeutic progress. However, evidence from a small open-label trial suggests that…”
Get full text